Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon

Regulatory Peptides

Volumn 85, Issue 2-3, 1999, Pages 87-92

  Ekblad, Eva ^a  

^a Sect Neuroendocrine Cell Biol   (Sweden)

Author keywords

Enteric nervous system; Gastro intestinal motility; Neuropeptide Y; Nitric oxide; PAC1 receptor; Pituitary adenylate cyclase activating peptide; Potassium channels; Vasoactive intestinal peptide; VIP specific receptors

Indexed keywords

7 NITROINDAZOLE; APAMIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNEL; TETRODOTOXIN; TETRYLAMMONIUM; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL MOTILITY; INTESTINE INNERVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION;

ANIMALS; APAMIN; COLON; FEMALE; INDAZOLES; MUSCLE RELAXATION; MUSCLE, SMOOTH; MYENTERIC PLEXUS; NEUROPEPTIDES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXADIAZOLES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; TETRODOTOXIN; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032741792     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00080-4     Document Type: Article

References (30)

1. Furness J.B., Young H.M., Pompolo S., Bornstein J.C., Kunze W.A.A., McConalogue K. Plurichemical transmission and chemical coding of neurons in the digestive tract. Gastroenterology. 108:1995;554-563.
2. Shuttleworth C.W.R., Keef K.D. Roles of peptides in enteric neuromuscular transmission. Regul Peptides. 56:1995;101-120.
3. Arimura A., Shioda S. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: Neuroendocrine and endocrine interaction. Front Neuroendocrinol. 6:1995;53-88.
4. Harmar A.J., Arimura A., Goxes I., Journot L., Laburthe M., Pisenga J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., Waschnek J.A. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev. 50:1998;265-270.
5. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distribution. Endocrinology. 135:1994;2662-2680.
6. Robberecht P., De Neef P., Lefebvre R.A. Influence of selective VIP receptor agonists in the rat gastric fundus. Eur J Pharmacol. 359:1998;77-80.
7. 3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells. Regul Peptides. 77:1998;127-134.
8. Ekblad E., Sundler F. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle. Eur J Pharmacol. 334:1997;61-66.
9. Katsoulis S., Schmidt W.E., Clemens A., Schwörer H., Creutzfeldt W. Vasoactive intestinal polypeptide induces neurogenic contraction of guinea pig ileum. Involvement of acetylcholine and substance P. Regul Peptides. 38:1992;155-164.
10. Katsoulis S., Clemens A., Schwörer H., Creutzfeldt W., Schmidt W.E. PACAP is a stimulator of neurogenic contraction in guinea pig ileum. Am J Physiol. 265:1993;G295-302.
11. Jin J.-G., Katsoulis S., Schmidt W.E., Grider J.R. Inhibitory transmission in taenia coli is mediated by distinct vasoactive intestinal peptide and apamin-sensitive pituitary adenylate cyclase activating peptide receptors. J Pharmacol Exp Ther. 270:1994;433-439.
12. McConalogue K., Furness J.B., Vremec M.A., Holst J.J., Tornoe K., Marley P.D. Histochemical, pharmacological, biochemical and chromatographic evidence that pituitary adenylate cyclase activating peptide is involved in inhibitory neurotransmission in the Taenia coli of the guinea pig caecum. J Autonom Nerv Syst. 50:1995;311-322.
13. Katsoulis S., Schmidt W.E. Role of PACAP in the regulation of gastrointestinal motility. Ann NY Acad Sci. 805:1997;364-378.
14. + channels. Br J Pharmacol. 119:1998;623-630.
15. Schworer H., Clemens A., Katsoulis S., Kohler H., Creutzfeldt W., Schmidt W.E. Pituitary adenylate cyclase-activating peptide is a potent modulator of human colonic motility. Scand J Gastroenterol. 28:1993;625-632.
16. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharm Rev. 43:1991;109-142.
17. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterisation of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol. 110:1993;219-224.
18. Brunner F., Schmidt K., Nielsen E.B., Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther. 277:1996;48-53.
19. + channels. J Physiol. 79:1984;259-264.
20. Castle N.A., Haylett D.G., Jenkinson D.H. Toxins in the characterisation of potassium channels. Trends Neurosci. 12:1989;59-66.
21. + channels in electrical activity of longitudinal and circular muscle layers of canine colon. Am J Physiol. 268:1995;C619-C627.
22. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
23. Pantaloni C., Brabet P., Bilanges B., Dumuis A., Houssami S., Spengler D., Bockaert J., Journot L. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem. 271:1996;22146-22151.
24. Robberecht P., Woussen-Colle M.C., De Neef P., Gourlet P., Buscail L., Vandermeers A., Vandermeers-Piret M.C., Christophe J. The two forms of the pituitary adenylate cyclase-activating polypeptide [PACAP(1-27) and PACAP(1-38)] interact with distinct receptors on rat pancreatic AR 4-2J cell membranes. FEBS Lett. 286:1991;133-136.
25. Shivers B.D., Gorcs T.J., Gottschall P.E., Arimura A. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distribution. Endocrinology. 128:1991;3055-3065.
26. Shuttleworth C.W.R., Koh S.D., Bayguinov O., Sanders K.M. Activation of delayed rectifier potassium channels in canine proximal colon by vasoactive intestinal peptide. J Physiol. 493:1996;651-663.
27. Ekblad E., Alm P., Sundler F. Distribution, origin and projections of nitric oxide synthase-containing neurons in gut and pancreas. Neuroscience. 63:1994;233-248.
28. Hannibal J., Ekblad E., Mulder H., Sundler F., Fahrenkrug J. Pituitary adenylate cyclase activating peptide (PACAP) in the gastrointestinal tract of the rat: Distribution and effects of capsaicin or denervation. Cell Tissue Res. 291:1998;65-79.
29. Ekblad E., Mulder H., Uddman R., Sundler F. NOS-containing neurons in the rat gut and coeliac ganglia. Neuropharmacology. 33:1994;1323-1331.
30. Grider J.R. Regulation of excitatory neural input to longitudinal intestinal muscle by myenteric interneurons. Am J Physiol. 275:1998;G973-978.